Ecological and evolutionary mechanisms driving within-patient emergence of antimicrobial resistance | Nature Reviews Microbiology nature.com/articles/s4157…

Headed to #ESCMIDGlobal ?

Want to know if there are any differences between C/T and CZA for the treatment of MDR P. aeruginosa?

Come watch Ryan Shields present FINAL data from CACTUS Tuesday.

🎯 210 matched pairs in analysis
🎯 28 (!!) sites in the USA contributed cases

Thegrowing threat of NDM-producing E. coli with penicillin-binding protein 3 mutations academic.oup.com/cid/advance-ar…

In vitro-in vivo discordance in β-lactams activities against MBL producing Enterobacterales has been described
🔥Deciphering the Efficacy of β-Lactams in the Face of MBL Derived Resistance in Enterobacterales
Supraphysiologic Zinc in Broth is the Culprit🔥 academic.oup.com/ofid/article/d…

AZT/AVI finally approved in Europe.
An important addition against the growing challenge of infections caused by metallo-beta-lactamase-producing Enterobacterales 💊 investors.pfizer.com/Investors/News…

Estos días estoy viendo muchos mensajes de nuevos MIR q han elegido plaza, contentos, orgullosos e ilusionados, ante su nueva aventura vital.

eurosurveillance.org/content/10.280…

Área Sanitaria da Coruña e Cee German Bou Jorge Arca Suárez CIBERINFEC

Our new paper is out! 🦠🧫

Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study | Eurosurveillance

Great teamwork! Congratulations especially to Cristina Lasarte and Pguisan GS

MicroCHUAC-INIBIC

🆕️⚡️ #JAC
A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant Pseudomonas aeruginosa #IDXposts academic.oup.com/jac/article-ab…

🆕 Ya está publicado el Informe Anual RedLabRA 2022 donde se analizan los datos recogidos durante el año 2022 en la vigilancia molecular de Klebsiella pneumoniae, Enterobacter cloacae complex y Escherichia coli productores de carbapenemasas en España

repisalud.isciii.es/handle/20.500.…

Check out our new paper👇🥦

Nationwide genome surveillance of carbapenem-resistant Pseudomonas aeruginosa in Japan | Antimicrobial Agents and Chemotherapy

Cesar Arias ASM

journals.asm.org/doi/10.1128/aa…

Cefepime BLI* combos:
📌Cefepime/zidebactam MBL-producing Enterobacterales & P.aeruginosa
🌟Cefepime/taniborbactam active against Ambler class A, B*, C & D β-lactamases
📌Cefepime/enmetazobactam & Cefepime/tazobactam :potential carbapenem-sparing agents w activity against ESBLs

'Está demostrado científicamente que los países que invierten más en investigación e innovación logran mayor bienestar y mejores democracias'. Cierto, Diana Morant
Demostrado también: España sigue muy por debajo de la media europea en la partida de I+D+I.

Sigan invirtiendo

Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage academic.oup.com/jac/article-ab…

The economics of antibiotics are broken and superbugs are on the rise–but a solution inspired by the subscription economy could save millions of lives fortune.com/2024/03/28/eco…

ECCMI2024 is one month away. Let's chek out ESGARS co-organised sessions #ECCMID2024 #ESGARS #AntimicrobialResistance

escmid.org/fileadmin/src/…

Staphylococcus aureus colonisation and strategies for decolonisation

doi.org/10.1016/S2666-…

🔴Hemos publicado una de las revisiones más completas sobre dosificación de antiinfecciosos en población obesa en ASM

Esperamos que sea de utiilidad! 😊

Gran trabajo Ana Castro Balado Teresa R Jato Cristina Mondelo Irene Zarra Beatriz Mejuto Pz del Molino FarmaCHUSLab @FarmaCHUS 😍

Our latest collaborative work analyzing the activity of cefiderocol and new BL/BLI combinations against isogenic strains of E. coli producing beta-lactamases under high and low permeability is out in IJAA! Great work, team! @GEMARA_SEIMC CIBERINFEC
sciencedirect.com/science/articl…